Search
Menu
Bristol Instruments, Inc. - 872 Series High-Res 4/24 LB

NinePoint Medical Inc.

Facebook X LinkedIn Email
A developer of medical devices for in vivo pathology, NinePoint Medical Inc. of Cambridge, Mass., has initiated a clinical trial to evaluate high-resolution optical imaging of Barrett’s esophagus, a common precursor to esophageal cancer, using its Nvision VLE imaging system. The system received 501(k) clearance from the FDA in January. The single-arm open-label observational trial is designed to evaluate the system’s performance in visualizing subsurface tissue in patients undergoing esophagogastroduodenoscopy for suspected or confirmed Barrett’s esophagus. It is expected to...Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: April 2012
    AmericasBiophotonicsBusinessesophageal cancerFDAImagingimaging of Barretts esophagusMassachusettsNinePoint MedicalNvision VLE imaging systemNvision VLE imaging system clinical trialOpticsRapidScanUS Food and Drug Administration

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.